Skip to content

Cognitive function and psychological capability in Post-Covid-19 syndrome

Cognitive function and psychological capability in Post-Covid-19 syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00029508
Enrollment
128
Registered
2022-07-14
Start date
2022-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Covid-Syndrome ICD-10:U09.9 F06.7

Interventions

Sponsors

Klinik für Allgemeine Psychiatrie, Universitätsklinikum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Ability to provide informed consent, age = 18 years, history of SARS-CoV-2 infection. Group 1: new or worsened psychiatric symptoms concerning affectivity, energy levels and tiredness, cognition or anxiety and stress related problems that have started after SARS-CoV-2 infection and are persistent on the day of examination, but no shorter than 12 weeks (so called post-covid-syndrom). Group 2: no residual symptoms of after SARS-CoV-2 infection.

Exclusion criteria

Exclusion criteria: 1. unable to provide informed consent 2. acute, severe somatic or psychiatric illnesses, such as: psychiatric: - acute psychosis - acute suicidal ideation - acute mania - acute intoxication - severe anxiety/OCD/depressive symptoms impeding the examination somatic: -acute neurologic or somatic illnesses that require medical attention such as acute infections, pain or injuries -persistent or chronic conditions that may impede the examination (particularly sensory or motor deficits)

Design outcomes

Primary

MeasureTime frame
Neuropsycholocial performance measured as sum score (z-score) in terms of a neuropsychological assessment, consisting of the dimensions attention (alertness and divided attention, psychomotor speed), concentration (d2-R), memory (visospatial memory, verbal memory), executive function (task switching, planning and decision making, response inhibition, verbal fluency)

Secondary

MeasureTime frame
Quality of life, depressive symptoms, subjectiv mental performance, fatigue symptoms, assessed by application of standardized questionnaires (WHOQoL, BDI-II, Flei, FQ-D).

Countries

Germany

Contacts

Public ContactJanina Eckhoff

Klinik für Allgemeine Psychiatrie am Universitätsklinikum Heidelberg, AG Neurokognition

janina.eckhoff@med.uni-heidelberg.de062215636201

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026